Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis

During tumor development, tumor cells constantly communicate with the surrounding microenvironment through both biochemical and biophysical cues. In particular, the tumor microenvironment can instruct carcinoma cells to undergo a morphogenesis program termed epithelial-to-mesenchymal transition (EMT...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cancer research 2015-03, Vol.21 (5), p.962-968
Hauptverfasser: Jung, Hae-Yun, Fattet, Laurent, Yang, Jing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 968
container_issue 5
container_start_page 962
container_title Clinical cancer research
container_volume 21
creator Jung, Hae-Yun
Fattet, Laurent
Yang, Jing
description During tumor development, tumor cells constantly communicate with the surrounding microenvironment through both biochemical and biophysical cues. In particular, the tumor microenvironment can instruct carcinoma cells to undergo a morphogenesis program termed epithelial-to-mesenchymal transition (EMT) to facilitate local invasion and metastatic dissemination. Growing evidence uncovered a plethora of microenvironmental factors in promoting EMT, including proinflammatory cytokines secreted by locally activated stromal cells, hypoxia conditions, extracellular matrix components, and mechanical properties. Here, we review various biochemical and biophysical factors in the tumor microenvironment that directly impinge upon the EMT program. Specifically, cytokines such as TGFβ, TNFα, and IL6 and hypoxia are capable of inducing EMT in various tumors. Several extracellular matrix (ECM) proteins, including collagen-I, fibronectin, and hyaluronan, and ECM remodeling via extracellular lysyl oxidase are also implicated in regulating EMT. In preclinical studies and ongoing clinical trials, targeting these tumor microenvironmental signals has shown promises in halting tumor progression in various human cancers.
doi_str_mv 10.1158/1078-0432.ccr-13-3173
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4320988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1660655354</sourcerecordid><originalsourceid>FETCH-LOGICAL-c581t-71e12986ce9765d1f9cda8563a6d1a6512a3b9136dc030304c50f26471beb88e3</originalsourceid><addsrcrecordid>eNpVUV1rFTEQDWKxtfoTlDz6sjWz2WSzPghyUVtoKYg-h9zs3N5oPq5JtuX-e3PpB5YZmIE5c2Y4h5B3wM4AhPoIbFQdG3h_Zm3ugHccRv6CnIAQY8d7KV62_hFzTF6X8psxGIANr8hxL9poAnFC8Cp5tIs3me5M3d6ZfflEvYt_XLyhdQkp0-BsThhvXU4xYKy0Joo7V7fonfFdwILRbvfBeFqzicVVlyJ1kQasprR05Q052hhf8O1DPSW_vn39uTrvLq-_X6y-XHZWKKjdCAj9pKTFaZRihs1kZ6OE5EbOYKSA3vD1BFzOlvEWgxVs08thhDWulUJ-Sj7f8-6WdcDZtm-z8XqXXTB5r5Nx-vkkuq2-Sbe6acQmpRrBhweCnP4uWKoOrlj03kRMS9EgJZNCcDE0qLiHNnVKybh5OgNMHyzSB_n1QX69Wv3QwPXBorb3_v8fn7YePeH_ADB_kKs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1660655354</pqid></control><display><type>article</type><title>Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Jung, Hae-Yun ; Fattet, Laurent ; Yang, Jing</creator><creatorcontrib>Jung, Hae-Yun ; Fattet, Laurent ; Yang, Jing</creatorcontrib><description>During tumor development, tumor cells constantly communicate with the surrounding microenvironment through both biochemical and biophysical cues. In particular, the tumor microenvironment can instruct carcinoma cells to undergo a morphogenesis program termed epithelial-to-mesenchymal transition (EMT) to facilitate local invasion and metastatic dissemination. Growing evidence uncovered a plethora of microenvironmental factors in promoting EMT, including proinflammatory cytokines secreted by locally activated stromal cells, hypoxia conditions, extracellular matrix components, and mechanical properties. Here, we review various biochemical and biophysical factors in the tumor microenvironment that directly impinge upon the EMT program. Specifically, cytokines such as TGFβ, TNFα, and IL6 and hypoxia are capable of inducing EMT in various tumors. Several extracellular matrix (ECM) proteins, including collagen-I, fibronectin, and hyaluronan, and ECM remodeling via extracellular lysyl oxidase are also implicated in regulating EMT. In preclinical studies and ongoing clinical trials, targeting these tumor microenvironmental signals has shown promises in halting tumor progression in various human cancers.</description><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>DOI: 10.1158/1078-0432.ccr-13-3173</identifier><identifier>PMID: 25107915</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Antineoplastic Agents - pharmacology ; Antineoplastic Agents - therapeutic use ; Clinical Trials as Topic ; Cytokines - genetics ; Cytokines - metabolism ; Epithelial-Mesenchymal Transition - drug effects ; Epithelial-Mesenchymal Transition - genetics ; Extracellular Matrix Proteins - genetics ; Extracellular Matrix Proteins - metabolism ; Humans ; Hypoxia - genetics ; Hypoxia - metabolism ; Molecular Targeted Therapy ; Neoplasm Metastasis ; Neoplasms - drug therapy ; Neoplasms - genetics ; Neoplasms - metabolism ; Neoplasms - pathology ; Signal Transduction - drug effects ; Translational Medical Research ; Treatment Outcome ; Tumor Microenvironment - drug effects ; Tumor Microenvironment - genetics</subject><ispartof>Clinical cancer research, 2015-03, Vol.21 (5), p.962-968</ispartof><rights>2014 American Association for Cancer Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c581t-71e12986ce9765d1f9cda8563a6d1a6512a3b9136dc030304c50f26471beb88e3</citedby><cites>FETCH-LOGICAL-c581t-71e12986ce9765d1f9cda8563a6d1a6512a3b9136dc030304c50f26471beb88e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,3357,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25107915$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jung, Hae-Yun</creatorcontrib><creatorcontrib>Fattet, Laurent</creatorcontrib><creatorcontrib>Yang, Jing</creatorcontrib><title>Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis</title><title>Clinical cancer research</title><addtitle>Clin Cancer Res</addtitle><description>During tumor development, tumor cells constantly communicate with the surrounding microenvironment through both biochemical and biophysical cues. In particular, the tumor microenvironment can instruct carcinoma cells to undergo a morphogenesis program termed epithelial-to-mesenchymal transition (EMT) to facilitate local invasion and metastatic dissemination. Growing evidence uncovered a plethora of microenvironmental factors in promoting EMT, including proinflammatory cytokines secreted by locally activated stromal cells, hypoxia conditions, extracellular matrix components, and mechanical properties. Here, we review various biochemical and biophysical factors in the tumor microenvironment that directly impinge upon the EMT program. Specifically, cytokines such as TGFβ, TNFα, and IL6 and hypoxia are capable of inducing EMT in various tumors. Several extracellular matrix (ECM) proteins, including collagen-I, fibronectin, and hyaluronan, and ECM remodeling via extracellular lysyl oxidase are also implicated in regulating EMT. In preclinical studies and ongoing clinical trials, targeting these tumor microenvironmental signals has shown promises in halting tumor progression in various human cancers.</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Clinical Trials as Topic</subject><subject>Cytokines - genetics</subject><subject>Cytokines - metabolism</subject><subject>Epithelial-Mesenchymal Transition - drug effects</subject><subject>Epithelial-Mesenchymal Transition - genetics</subject><subject>Extracellular Matrix Proteins - genetics</subject><subject>Extracellular Matrix Proteins - metabolism</subject><subject>Humans</subject><subject>Hypoxia - genetics</subject><subject>Hypoxia - metabolism</subject><subject>Molecular Targeted Therapy</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Signal Transduction - drug effects</subject><subject>Translational Medical Research</subject><subject>Treatment Outcome</subject><subject>Tumor Microenvironment - drug effects</subject><subject>Tumor Microenvironment - genetics</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUV1rFTEQDWKxtfoTlDz6sjWz2WSzPghyUVtoKYg-h9zs3N5oPq5JtuX-e3PpB5YZmIE5c2Y4h5B3wM4AhPoIbFQdG3h_Zm3ugHccRv6CnIAQY8d7KV62_hFzTF6X8psxGIANr8hxL9poAnFC8Cp5tIs3me5M3d6ZfflEvYt_XLyhdQkp0-BsThhvXU4xYKy0Joo7V7fonfFdwILRbvfBeFqzicVVlyJ1kQasprR05Q052hhf8O1DPSW_vn39uTrvLq-_X6y-XHZWKKjdCAj9pKTFaZRihs1kZ6OE5EbOYKSA3vD1BFzOlvEWgxVs08thhDWulUJ-Sj7f8-6WdcDZtm-z8XqXXTB5r5Nx-vkkuq2-Sbe6acQmpRrBhweCnP4uWKoOrlj03kRMS9EgJZNCcDE0qLiHNnVKybh5OgNMHyzSB_n1QX69Wv3QwPXBorb3_v8fn7YePeH_ADB_kKs</recordid><startdate>20150301</startdate><enddate>20150301</enddate><creator>Jung, Hae-Yun</creator><creator>Fattet, Laurent</creator><creator>Yang, Jing</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150301</creationdate><title>Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis</title><author>Jung, Hae-Yun ; Fattet, Laurent ; Yang, Jing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c581t-71e12986ce9765d1f9cda8563a6d1a6512a3b9136dc030304c50f26471beb88e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Clinical Trials as Topic</topic><topic>Cytokines - genetics</topic><topic>Cytokines - metabolism</topic><topic>Epithelial-Mesenchymal Transition - drug effects</topic><topic>Epithelial-Mesenchymal Transition - genetics</topic><topic>Extracellular Matrix Proteins - genetics</topic><topic>Extracellular Matrix Proteins - metabolism</topic><topic>Humans</topic><topic>Hypoxia - genetics</topic><topic>Hypoxia - metabolism</topic><topic>Molecular Targeted Therapy</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Signal Transduction - drug effects</topic><topic>Translational Medical Research</topic><topic>Treatment Outcome</topic><topic>Tumor Microenvironment - drug effects</topic><topic>Tumor Microenvironment - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jung, Hae-Yun</creatorcontrib><creatorcontrib>Fattet, Laurent</creatorcontrib><creatorcontrib>Yang, Jing</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jung, Hae-Yun</au><au>Fattet, Laurent</au><au>Yang, Jing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis</atitle><jtitle>Clinical cancer research</jtitle><addtitle>Clin Cancer Res</addtitle><date>2015-03-01</date><risdate>2015</risdate><volume>21</volume><issue>5</issue><spage>962</spage><epage>968</epage><pages>962-968</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><abstract>During tumor development, tumor cells constantly communicate with the surrounding microenvironment through both biochemical and biophysical cues. In particular, the tumor microenvironment can instruct carcinoma cells to undergo a morphogenesis program termed epithelial-to-mesenchymal transition (EMT) to facilitate local invasion and metastatic dissemination. Growing evidence uncovered a plethora of microenvironmental factors in promoting EMT, including proinflammatory cytokines secreted by locally activated stromal cells, hypoxia conditions, extracellular matrix components, and mechanical properties. Here, we review various biochemical and biophysical factors in the tumor microenvironment that directly impinge upon the EMT program. Specifically, cytokines such as TGFβ, TNFα, and IL6 and hypoxia are capable of inducing EMT in various tumors. Several extracellular matrix (ECM) proteins, including collagen-I, fibronectin, and hyaluronan, and ECM remodeling via extracellular lysyl oxidase are also implicated in regulating EMT. In preclinical studies and ongoing clinical trials, targeting these tumor microenvironmental signals has shown promises in halting tumor progression in various human cancers.</abstract><cop>United States</cop><pmid>25107915</pmid><doi>10.1158/1078-0432.ccr-13-3173</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1078-0432
ispartof Clinical cancer research, 2015-03, Vol.21 (5), p.962-968
issn 1078-0432
1557-3265
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4320988
source MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Animals
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Clinical Trials as Topic
Cytokines - genetics
Cytokines - metabolism
Epithelial-Mesenchymal Transition - drug effects
Epithelial-Mesenchymal Transition - genetics
Extracellular Matrix Proteins - genetics
Extracellular Matrix Proteins - metabolism
Humans
Hypoxia - genetics
Hypoxia - metabolism
Molecular Targeted Therapy
Neoplasm Metastasis
Neoplasms - drug therapy
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Signal Transduction - drug effects
Translational Medical Research
Treatment Outcome
Tumor Microenvironment - drug effects
Tumor Microenvironment - genetics
title Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T11%3A00%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20pathways:%20linking%20tumor%20microenvironment%20to%20epithelial-mesenchymal%20transition%20in%20metastasis&rft.jtitle=Clinical%20cancer%20research&rft.au=Jung,%20Hae-Yun&rft.date=2015-03-01&rft.volume=21&rft.issue=5&rft.spage=962&rft.epage=968&rft.pages=962-968&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/10.1158/1078-0432.ccr-13-3173&rft_dat=%3Cproquest_pubme%3E1660655354%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1660655354&rft_id=info:pmid/25107915&rfr_iscdi=true